Ja‐Young Jeon

1.1k total citations
34 papers, 868 citations indexed

About

Ja‐Young Jeon is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Ja‐Young Jeon has authored 34 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Rheumatology, 20 papers in Immunology and 6 papers in Hematology. Recurrent topics in Ja‐Young Jeon's work include Systemic Lupus Erythematosus Research (15 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Ja‐Young Jeon is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and Autoimmune and Inflammatory Disorders Research (6 papers). Ja‐Young Jeon collaborates with scholars based in South Korea, Japan and Canada. Ja‐Young Jeon's co-authors include Chang‐Hee Suh, Hyoun‐Ah Kim, Seung‐Hyun Kim, Hae‐Sim Park, Jeong‐Moon Yun, Jae-Wook Chung, Young‐Min Ye, Ju‐Yang Jung, Yoo Sang Baek and Je Hyeong Kim and has published in prestigious journals such as Scientific Reports, Annals of the Rheumatic Diseases and Journal of Investigative Dermatology.

In The Last Decade

Ja‐Young Jeon

34 papers receiving 845 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ja‐Young Jeon South Korea 16 497 474 158 129 112 34 868
Linda Nalotto Italy 14 706 1.4× 577 1.2× 186 1.2× 97 0.8× 135 1.2× 20 1.2k
Elena Elefante Italy 19 644 1.3× 312 0.7× 132 0.8× 86 0.7× 141 1.3× 72 1.0k
M. de Longueville Belgium 15 537 1.1× 376 0.8× 107 0.7× 190 1.5× 61 0.5× 30 1.2k
Xiaomei Leng China 15 408 0.8× 417 0.9× 101 0.6× 75 0.6× 92 0.8× 79 855
Rosario Foti Italy 16 427 0.9× 183 0.4× 85 0.5× 170 1.3× 133 1.2× 93 986
G. Castellino Italy 17 623 1.3× 343 0.7× 80 0.5× 81 0.6× 185 1.7× 32 934
Yeong Wook Song South Korea 19 319 0.6× 201 0.4× 201 1.3× 61 0.5× 94 0.8× 44 921
Lindi Jiang China 17 318 0.6× 245 0.5× 144 0.9× 95 0.7× 88 0.8× 78 893
Yannick Degboé France 20 563 1.1× 342 0.7× 231 1.5× 214 1.7× 110 1.0× 70 1.1k
Yair Molad Israel 15 368 0.7× 229 0.5× 84 0.5× 102 0.8× 57 0.5× 29 692

Countries citing papers authored by Ja‐Young Jeon

Since Specialization
Citations

This map shows the geographic impact of Ja‐Young Jeon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ja‐Young Jeon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ja‐Young Jeon more than expected).

Fields of papers citing papers by Ja‐Young Jeon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ja‐Young Jeon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ja‐Young Jeon. The network helps show where Ja‐Young Jeon may publish in the future.

Co-authorship network of co-authors of Ja‐Young Jeon

This figure shows the co-authorship network connecting the top 25 collaborators of Ja‐Young Jeon. A scholar is included among the top collaborators of Ja‐Young Jeon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ja‐Young Jeon. Ja‐Young Jeon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Yong Hyun, Eun‐Young Choi, Hyesung Lee, et al.. (2024). Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis. JAMA Network Open. 7(7). e2423563–e2423563. 5 indexed citations
2.
Cho, Soo‐Kyung, Hyoungyoung Kim, Eunwoo Nam, et al.. (2023). Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study. Scientific Reports. 13(1). 7877–7877. 4 indexed citations
3.
Kim, Seong‐Kyu, Sang‐Heon Lee, Jiyu Sun, et al.. (2023). Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumab. Arthritis Research & Therapy. 25(1). 68–68. 2 indexed citations
4.
Lee, Ji Hyun, et al.. (2022). Real-world treatment patterns for atopic dermatitis in South Korea. Scientific Reports. 12(1). 13626–13626. 6 indexed citations
5.
6.
Koo, Bon San, et al.. (2021). Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis. Rheumatology and Therapy. 8(1). 347–359. 3 indexed citations
7.
8.
Bang, Chul Hwan, et al.. (2018). 578 Acne severity scoring using deep learning. Journal of Investigative Dermatology. 138(5). S98–S98. 2 indexed citations
9.
Baek, Yoo Sang, Ja‐Young Jeon, Je Hyeong Kim, & Chil Hwan Oh. (2014). Severity of acute and chronic urticaria correlates with D-dimer level, but not C-reactive protein or total IgE. Clinical and Experimental Dermatology. 39(7). 795–800. 33 indexed citations
10.
Suh, Chang‐Hee, et al.. (2014). Serum S100A12 May Be a Useful Biomarker of Disease Activity in Adult-onset Still’s Disease. The Journal of Rheumatology. 41(12). 2403–2408. 38 indexed citations
11.
Kim, Hyoun‐Ah, et al.. (2014). Serum growth arrest-specific protein 6 levels are elevated in adult-onset Still’s disease. Clinical Rheumatology. 33(6). 865–868. 1 indexed citations
12.
13.
Kim, Hyoun‐Ah, et al.. (2012). Serum Growth Arrest-Specific Protein 6 Levels are a Reliable Biomarker of Disease Activity in Systemic Lupus Erythematosus. Journal of Clinical Immunology. 33(1). 143–150. 22 indexed citations
14.
Kim, Hyoun‐Ah, et al.. (2012). Serum S100A8/A9, But Not Follistatin-like Protein 1 and Interleukin 18, May Be a Useful Biomarker of Disease Activity in Adult-onset Still’s Disease. The Journal of Rheumatology. 39(7). 1399–1406. 58 indexed citations
15.
Jeon, Ja‐Young, Hyoun‐Ah Kim, Seung‐Hyun Kim, & Chang‐Hee Suh. (2011). Association between variable number tandem repeats within the 3′ flanking region of the interleukin-6 gene and systemic lupus erythematosus in Korean patients. Lupus. 20(11). 1161–1165. 4 indexed citations
16.
Kim, Hyoun‐Ah, et al.. (2010). Vitamin D may not be a good marker of disease activity in Korean patients with systemic lupus erythematosus. Rheumatology International. 31(9). 1189–1194. 58 indexed citations
17.
Kim, Hyoun‐Ah, et al.. (2010). Beta2-Microglobulin Can Be a Disease Activity Marker in Systemic Lupus Erythematosus. The American Journal of the Medical Sciences. 339(4). 337–340. 28 indexed citations
18.
Jeon, Ja‐Young, Hyoun‐Ah Kim, Seung‐Hyun Kim, Hae‐Sim Park, & Chang‐Hee Suh. (2010). Interleukin 6 Gene Polymorphisms Are Associated with Systemic Lupus Erythematosus in Koreans. The Journal of Rheumatology. 37(11). 2251–2258. 22 indexed citations
19.
Kim, Hyoun‐Ah, et al.. (2009). Leptin and ghrelin in Korean systemic lupus erythematosus. Lupus. 19(2). 170–174. 32 indexed citations
20.
Kim, Hyoun‐Ah, et al.. (2008). The antichromatin antibodies can be useful as a diagnostic tool and disease activity marker of systemic lupus erythematosus in Koreans. Clinical Immunology. 128(2). 277–283. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Nalotto Breakdown of academic impact, for papers by Elena Elefante Breakdown of academic impact, for papers by M. de Longueville Breakdown of academic impact, for papers by Xiaomei Leng Breakdown of academic impact, for papers by Rosario Foti Breakdown of academic impact, for papers by G. Castellino Breakdown of academic impact, for papers by Yeong Wook Song Breakdown of academic impact, for papers by Lindi Jiang Breakdown of academic impact, for papers by Yannick Degboé Breakdown of academic impact, for papers by Yair Molad
Rankless by CCL
2026